dimyristoylphosphatidylcholine has been researched along with Cholangiocarcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kariya, R; Kobayashi, N; Komizu, Y; Matsumoto, Y; Okada, S; Suzu, S; Towata, T; Ueoka, R; Wongkham, C; Wongkham, S | 1 |
1 other study(ies) available for dimyristoylphosphatidylcholine and Cholangiocarcinoma
| Article | Year |
|---|---|
Hybrid liposomes inhibit the growth of cholangiocarcinoma by induction of cell cycle arrest in G1 phase.
Topics: Bile Ducts, Intrahepatic; Cell Cycle; Cell Proliferation; Cholangiocarcinoma; Dimyristoylphosphatidylcholine; G1 Phase; Humans; Liposomes; Polyethylene Glycols; Tumor Cells, Cultured | 2010 |